blueBriX digital health platform expands into pharmaceutical sector

The digital health platform blueBriX has entered the pharmaceutical sector, offering a software solution that complies with medical device regulations. This expansion aims to enhance patient experience and drive revenue growth for pharmaceutical companies.

blueBriX offers a comprehensive collection of customisable health tech components, serving as the fundamental building blocks for digital health solutions. Users can seamlessly integrate their newly created solutions with existing digital systems, medical devices, prescription services, and consumer wearables within the broader healthcare ecosystem.

Currently, the platform is actively engaging with the UK market, and its entry into the pharmaceutical sector marks a significant milestone. Leveraging its library of health tech components, modules, and APIs, blueBriX has facilitated the development of agile and innovative digital health solutions, thereby elevating healthcare standards worldwide.

Pharmacies are increasingly assuming the role of medical hubs, assisting patients in managing various health conditions. In recognition of this expanded role, the Professional Record Standards Body (PRSB) extended its community pharmacy information standard in 2021.